Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Syndax Pharmaceuticals, Inc. (SNDX)

Logo grafis Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals (SNDX) faces significant risk concentration due to its high dependence on regulatory approvals. The quarterly EPS growth rate reflects the performance of management, whose transparency regarding the FDA and expertise in commercializing inhibitors warrant close attention. Revenues are based on licenses and grants for target molecules. The current value of the parameter is 21.40, confirming the sensitivity of profits to external factors.

Syndax Pharmaceuticals, Inc. (SNDX) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan saka 04.07.2022 nganti 16.11.2026

Rincian analitis perusahaan Syndax Pharmaceuticals

- nilai pasar lan prakiraan target analis:
Ringkesan analisis perusahaan:Syndax Pharmaceuticals - SNDX
Produk dadi Syndax Pharmaceuticals

The fundamental attractiveness of Syndax Pharmaceuticals (SNDX) is determined by its ability to generate net earnings per share. The quarterly EPS trend reflects real growth in profitability, stripping speculative noise from the quotes. This metric measures the efficiency of business capitalization, allowing investors to distinguish market euphoria from actual financial progress. The stability of this indicator is supported by minimal turnover among key biochemists. The targeted hiring of commercialization experts should transform scientific achievements into sustainable profit growth.

Pesaing wigati

tgtherapeutics.com (TGTX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Arcellx Therapeutics (ACLX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Disc Medicine Inc|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Kura Oncology, Inc. KURA|Wutah bathi EPS kuartalan ADCT|Foghorn Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan vorbio.com VOR|NKTX: Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|COEP - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Actinium Pharmaceuticals, Inc. (ATNM) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|ESLA (Estrella Immunopharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|CASI - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Marker Bio|Wutah bathi EPS kuartalan IN8bio, Inc.|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Eterna Therapeutics Inc (ERNA)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan gtbiopharma.com|Wutah bathi EPS kuartalan APTO (Aptose Biosciences)|Wutah bathi EPS kuartalan Bio-Path BPTH|MEI Pharma Inc - Wutah bathi EPS kuartalan|VINC (Vincerx Pharma Inc.) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan